BRILAROXAZINE
UNII X8L60BA01I

Substance Identification & Data

This profile provides standardized clinical and technical data for Brilaroxazine, uniquely identified by the FDA Unique Ingredient Identifier (UNII) X8L60BA01I.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1239729-06-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

X8L60BA01I

CAS Registry Number

1239729-06-6

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

BRILAROXAZINE

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C22H25Cl2N3O3

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

PMKMNTBZJOXTJW-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C169817

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

46861612

Unique identification number in the NCBI database of chemical substances.

INN ID

10819

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

MN-10

Identifier assigned by the United States Adopted Names Council.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

O1c2c(NC(C1)=O)cc(cc2)OCCCCN3CCN(CC3)c4c(c(ccc4)Cl)Cl

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Brilaroxazine. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.